ondansetron has been researched along with Bone Diseases in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Bone Diseases: Diseases of BONES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donovan-Rodriguez, T | 1 |
| Urch, CE | 1 |
| Dickenson, AH | 1 |
| Cubukçu, Z | 1 |
| Ozbek, H | 1 |
| Güneş, Y | 1 |
| Gündüz, M | 1 |
| Ozcengiz, D | 1 |
| Işik, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pain Phenotyping of Patients With Bone Cancer Pain[NCT03908853] | 70 participants (Anticipated) | Observational | 2019-02-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ondansetron and Bone Diseases
| Article | Year |
|---|---|
[Effect of ondansetron in lower extremity bone surgery on morphine and tramadol consumption using patient controlled analgesia].
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Anxiety Agents; Bone Diseases; Drug A | 2007 |
1 other study available for ondansetron and Bone Diseases
| Article | Year |
|---|---|
Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain.
Topics: Animals; Behavior, Animal; Bone Diseases; Cell Line, Tumor; Disease Models, Animal; Dose-Response Re | 2006 |